Telos Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.41M Sell
25,990
-22
-0.1% -$7.53K 0.83% 37
2026
Q1
$9.15M Sell
26,012
-978
-4% -$349K 0.88% 41
2025
Q4
$8.83M Sell
26,990
-832
-3% -$264K 0.82% 41
2025
Q3
$7.85M Buy
27,822
+150
+0.5% +$43.5K 0.75% 47
2025
Q2
$7.73M Buy
27,672
+1,912
+7% +$542K 0.79% 45
2025
Q1
$8.03M Sell
25,760
-237
-0.9% -$70K 0.87% 34
2024
Q4
$6.78M Buy
25,997
+797
+3% +$236K 0.72% 52
2024
Q3
$8.12M Sell
25,200
-357
-1% -$117K 0.85% 38
2024
Q2
$7.99M Buy
25,557
+1,088
+4% +$320K 0.89% 37
2024
Q1
$6.96M Sell
24,469
-31
-0.1% -$9.07K 0.78% 42
2023
Q4
$7.06M Sell
24,500
-225
-0.9% -$61.3K 0.86% 37
2023
Q3
$6.65M Sell
24,725
-1,754
-7% -$438K 0.92% 34
2023
Q2
$5.88M Buy
26,479
+205
+0.8% +$47.6K 0.78% 40
2023
Q1
$6.35M Buy
26,274
+2,435
+10% +$598K 0.89% 38
2022
Q4
$6.26M Sell
23,839
-705
-3% -$189K 0.91% 36
2022
Q3
$5.53M Buy
24,544
+253
+1% +$61.3K 0.91% 37
2022
Q2
$5.91M Sell
24,291
-241
-1% -$59.1K 0.9% 39
2022
Q1
$5.93M Buy
24,532
+450
+2% +$103K 0.77% 44
2021
Q4
$5.42M Buy
24,082
+1,387
+6% +$293K 0.68% 52
2021
Q3
$4.83M Buy
22,695
+113
+0.5% +$26K 0.66% 52
2021
Q2
$5.5M Sell
22,582
-236
-1% -$58.1K 0.73% 48
2021
Q1
$5.68M Buy
22,818
+418
+2% +$99.7K 0.82% 38
2020
Q4
$5.15M Buy
22,400
+1,417
+7% +$327K 0.78% 40
2020
Q3
$5.33M Sell
20,983
-349
-2% -$86.5K 0.93% 32
2020
Q2
$5.03M Sell
21,332
-614
-3% -$140K 0.97% 33
2020
Q1
$4.45M Buy
21,946
+1,649
+8% +$360K 1.1% 28
2019
Q4
$4.89M Buy
20,297
+2,196
+12% +$484K 1.12% 25
2019
Q3
$3.5M Buy
18,101
+633
+4% +$122K 0.96% 40
2019
Q2
$3.22M Buy
17,468
+826
+5% +$148K 0.94% 43
2019
Q1
$3.16M Buy
16,642
+1,187
+8% +$227K 0.99% 41
2018
Q4
$3.01M Buy
15,455
+251
+2% +$49K 1.11% 31
2018
Q3
$3.15M Sell
15,204
-223
-1% -$43.9K 1.01% 34
2018
Q2
$2.85M Buy
15,427
+62
+0.4% +$11K 0.98% 38
2018
Q1
$2.62M Buy
15,365
+220
+1% +$40.4K 0.93% 43
2017
Q4
$2.63M Buy
15,145
+743
+5% +$131K 0.93% 44
2017
Q3
$2.69M Sell
14,402
-396
-3% -$70.2K 1.04% 38
2017
Q2
$2.55M Buy
14,798
+450
+3% +$73.2K 1.02% 36
2017
Q1
$2.35M Buy
14,348
+227
+2% +$37.7K 0.98% 40
2016
Q4
$2.06M Buy
14,121
+957
+7% +$144K 0.92% 46
2016
Q3
$2.2M Buy
13,164
+382
+3% +$64.6K 1.02% 34
2016
Q2
$1.95M Buy
12,782
+274
+2% +$42.6K 0.95% 41
2016
Q1
$1.88M Buy
12,508
+852
+7% +$127K 0.98% 36
2015
Q4
$1.89M Buy
+11,656
New +$1.83M 1.02% 36
2015
Q2
Sell
-2,411
Closed -$385K 143
2015
Q1
$385K Sell
2,411
-100
-4% -$15.7K 0.22% 105
2014
Q4
$400K Sell
2,511
-150
-6% -$23.4K 0.24% 108
2014
Q3
$374K Buy
2,661
+376
+16% +$49.1K 0.23% 111
2014
Q2
$270K Sell
2,285
-100
-4% -$11.6K 0.17% 127
2014
Q1
$294K Buy
+2,385
New +$289K 0.21% 127

Other funds holding AMGN

Telos Capital Management's AMGN Position: Q2 2026 in Review

Telos Capital Management reduced its Amgen (AMGN) stake by 0.08% in Q2 2026, selling an estimated $7.53K and leaving 25,990 shares worth $9.41M. The position accounts for 0.83% of the portfolio, ranked #37.

Telos Capital Management first reported a position in AMGN in Q1 2014 and has held it in 48 quarters since. 1,081 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Telos Capital Management held 25,990 shares of Amgen worth $9.41M as of Q2 2026.
  • Telos Capital Management sold 22 Amgen shares in Q2 2026, an estimated $7.53K.
  • Amgen made up 0.83% of Telos Capital Management's portfolio in Q2 2026, its #37 holding.
  • Telos Capital Management first reported a position in Amgen in Q1 2014 and has held it in 48 quarters since.
  • 1,081 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.